Mechanistic comparison of 3345 tetrachlorosalicylanilide and sinapinate based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
2
Shared Targets
40%
Jaccard Similarity
34%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
3345 and sinapinate share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.400 means 40% of the combined target set is bound by both compounds. The IDF-weighted score of 0.343 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do 3345 and sinapinate have in common?
3345 and sinapinate share 2 molecular targets with a Jaccard similarity of 40%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can 3345 and sinapinate be combined?
3345 and sinapinate share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: 3345 or sinapinate?
Both 3345 and sinapinate have substantial PubMed research. View their individual profiles for full evidence scores.